ANTIARRHYTHMIC DRUGS - ELECTROPHYSIOLOGICAL AND PHARMACOKINETIC CONSIDERATIONS

被引：56
作者：
SASYNIUK, BI [1 ]
OGILVIE, RI [1 ]
机构：
[1] MCGILL UNIV, DEPT PHARMACOL & THERAPEUTICS, MONTREAL, QUEBEC, CANADA
来源：
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY | 1975年 / 15卷
关键词：
D O I：
10.1146/annurev.pa.15.040175.001023
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：131 / 155
页数：25
相关论文
共 252 条
[1]  
ANDREASEN F, 1973, ACTA PHARMACOL TOX, V32, P417
[2]  
ANTMAN E M, 1973, Circulation Supplement, V48, pIV
[3]  
ARMAND J, 1969, MED EXP, V19, P22
[4]  
ARMAND J, 1972, ANN BIOL CLIN-PARIS, V30, P599
[5]  
ARNOLD K, 1970, CLIN PHARMACOL THER, V11, P121
[6]   EFFECT OF LIDOCAINE HYDROCHLORIDE ON MEMBRANE CONDUCTANCE IN MAMMALIAN CARDIAC PURKINJE FIBERS [J].
ARNSDORF, MF ;
BIGGER, JT .
JOURNAL OF CLINICAL INVESTIGATION, 1972, 51 (09) :2252-+
[7]  
ASTROM A, 1971, LIDOCAINE TREATMENT, P128
[8]  
ATKINSON AJ, 1973, CLIN PHARMACOL THER, V14, P521
[9]   TREATMENT OF DIGITALIS TOXICITY BY DIPHENYLHYDANTOIN (DILANTIN) [J].
BASHOUR, FA ;
EDMONSON, RE ;
GUPTA, DN ;
PRATI, R .
DISEASES OF THE CHEST, 1968, 53 (03) :263-&
[10]   USE OF LIDOCAINE BY CONTINUOUS INFUSION [J].
BASSAN, MM ;
WEINSTEIN, SR ;
MANDEL, WJ .
AMERICAN HEART JOURNAL, 1974, 87 (03) :302-303
12345678910